LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 2 | D18 | 72 | hr | 1311 | 5232 | 5100 | 1.0259 | 1.0263 |
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 3 | D18 | 72 | hr | 1311 | 4928 | 5010 | 0.9835 | 0.9828 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 1 | D17 | 72 | hr | 1311 | 4776 | 5128 | 0.9313 | 0.9289 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 1311 | 5230 | 5100 | 1.0255 | 1.0259 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 1311 | 4952 | 5010 | 0.9883 | 0.9878 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 1311 | 4882 | 5128 | 0.9520 | 0.9506 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 1311 | 5175 | 5100 | 1.0147 | 1.0150 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 1311 | 4458 | 5010 | 0.8897 | 0.8827 |
MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 1 | D15 | 72 | hr | 1311 | 4475 | 5128 | 0.8726 | 0.8661 |
MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 2 | D15 | 72 | hr | 1311 | 4942 | 5100 | 0.9690 | 0.9681 |
MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 3 | D15 | 72 | hr | 1311 | 4700 | 5010 | 0.9380 | 0.9348 |
MDA-MB-231 | Enzastaurin | 3.33 | uM | LJP5 | 1 | D14 | 72 | hr | 1311 | 4938 | 5128 | 0.9629 | 0.9619 |
MDA-MB-231 | Enzastaurin | 3.33 | uM | LJP5 | 2 | D14 | 72 | hr | 1311 | 5082 | 5100 | 0.9965 | 0.9964 |
MDA-MB-231 | Enzastaurin | 3.33 | uM | LJP5 | 3 | D14 | 72 | hr | 1311 | 4731 | 5010 | 0.9442 | 0.9414 |
MDA-MB-231 | Enzastaurin | 10 | uM | LJP5 | 1 | D13 | 72 | hr | 1311 | 5150 | 5128 | 1.0042 | 1.0043 |
MDA-MB-231 | Enzastaurin | 10 | uM | LJP5 | 2 | D13 | 72 | hr | 1311 | 5111 | 5100 | 1.0022 | 1.0022 |
MDA-MB-231 | Enzastaurin | 10 | uM | LJP5 | 3 | D13 | 72 | hr | 1311 | 5167 | 5010 | 1.0312 | 1.0320 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 1311 | 3372 | 4870 | 0.6924 | 0.6469 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 1311 | 3930 | 4961 | 0.7921 | 0.7713 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 1311 | 3602 | 4973 | 0.7242 | 0.6910 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 1 | E17 | 72 | hr | 1311 | 3210 | 4870 | 0.6591 | 0.6046 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 2 | E17 | 72 | hr | 1311 | 3341 | 4961 | 0.6734 | 0.6276 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 3 | E17 | 72 | hr | 1311 | 3318 | 4973 | 0.6671 | 0.6203 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 1311 | 2805 | 4870 | 0.5760 | 0.4942 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 1311 | 3268 | 4961 | 0.6587 | 0.6090 |